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INTRODUCTION
Phenolics are compounds possessing one or 
more aromatic rings with one or more hydrox-
yl groups. They are broadly distributed in the plant 
kingdom and are the most abundant secondary me-
tabolites of plants, with more than 8,000 pheno-
lic structures currently known. Despite their wide 
distribution, the health effects of polyphenols have 
come to the attention of nutritionists in recent years. 
The preventive effects of these plant metabolites in 
terms of cardiovascular, neurodegenerative diseases 
and cancer are deduced from epidemiologic data as 
well as in vitro and in vivo (1,3,6,9,19). Among these 
compounds flavonoids and phenolic acids consti-
tute one of the most ubiquitous groups of all plant 
phenolics. 
Flavonoids are constituents of fruits, vegetables, 
plant-derived beverages as tea and wine, as well as 
components present in dietary supplements.  Over 
4 000 different naturally occurring flavonoids have 
been described (11). Phenolic acids (hydroxycinnam-
ica and hydroxvbenzoic acids) belong to the group 
of phenolic compounds as well, and occur in fruits 
as esters glycosideas and amides. The most common 
hydroxycinnamic acids are p-coumaric, caffeic and 
ferulic acid, while the corresponding hydroxybenzo-
ic acids are p-hydroxybenzoic, gallic, ellagic, 3,4-di-
hydroxybenzoic, vanillic, and syringic acid (5). 
However, the potential toxicity of these two 
types of phenolic components has not been well 
studied (7).
In the recent years methods for structural fea-
tures and properties of a molecule and its impact on 
biological activity were investigated. One of them 
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is Quantitative Structure-Activity Relationship 
(QSAR) - a method of studying a series of molecules 
of different structures with varying observed prop-
erties and attempting to find empirical relationships 
between structure and property or activity. QSAR 
has been widely used for new drug discovery pro-
cesses, but also for the prediction of metabolism and 
toxicity of chemical structures (14).
The aim of this work is to predict the possible 
metabolites of some plant phenolic compounds by 
a specialized software OECD - (Q)SAR Application 
Toolbox. Analysis of data reveals that after metabol-
ic activation in liver (observed pathways) for five of 
the six plant phenolic compounds liver metabolism 
was not observed. Only for one compound (Luteo-
№ CAS number Name of compound Structure of compound
Table 1. CAS number, name and structure of some phenolic compounds
1 327-97-9 Chlorogenic acid 
2 530-59-6 Sinapinic acid 
3 1135-24-6 Ferulic acid 
4 491-70-3 Luteolin 
5 520-18-3 Kaemferol 
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lin) metabolic activation in liver (observed pathways) 
was observed. 
MATERIAL AND METHODS
Compounds. Some investigated phenolic com-
pounds (2) are presented in Table 1. 
OECD (Q)SAR Application Toolbox. (Quan-
titative) Structure-Activity Relationships [(Q)
SARs] are methods for estimating the properties of 
a chemical from its molecular structure and have 
the potential to provide information on the haz-
ards of chemicals, while reducing time, monetary 
costs and animal testing currently needed. To fa-
cilitate practical application of (Q)SAR approaches 
in regulatory contexts by governments and indus-
try and to improve their regulatory acceptance, the 
Table 2. Probable metabolic activation of some plant phenolic compounds by (Q)SAR Application Toolbox








 0 metabolites: 2 metabolites:  
- Protein binding – No binding; 
- DNA binding - No binding; 
       1)                                        2) 
2 Sinapinic 
acid
 0 metabolites:  13 metabolites:  
- Protein binding – Michael-type nucleophilic addition; 
- DNA binding - No binding; 
        1)                                2)  
- Protein binding – Schiff base formation; 
- DNA binding - No binding; 
3)
- Protein binding – No binding; 
- DNA binding - No binding; 
       
           4)                     5)                      6) 
           7)                     8)                      9) 
          10)                   11)                    12) 
- Protein binding – Michael-type nucleophilic addition 
and Nucleophilic cycloaddition to diketones; 
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3 Ferulic acid  0 metabolites: 11 metabolites:  
- Protein binding – Michael-type nucleophilic addition; 
- DNA binding - No binding; 
1)
- Protein binding – Schiff base formation; 
- DNA binding - No binding; 
2)
- Protein binding – No binding; 
- DNA binding - No binding; 
             3)                      4)                       5) 
   
             6)                     7)                      8) 
            9)                    10) 
- Protein binding – Michael-type nucleophilic addition 
and Nucleophilic cycloaddition to diketones; 
































4 Luteolin 3 metabolites: 
- Protein binding – Michael-type 
nucleophilic addition; 
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OECD (Q)SAR project has developed various out-
comes such as the principles for the validation of 
(Q)SAR models, guidance documents as well as the 
QSAR Toolbox (15).
Metabolic pathways documented for 200 or-
ganic chemicals in different mammals are stored in a 
database format that allows easy computer-aided ac-
cess to the metabolism information. The collection 
includes chemicals of different classes, with variety 
of functionalities such as aliphatic hydrocarbons, ali-
cyclic rings, furans, halogenated hydrocarbons, aro-
matic hydrocarbons and haloaromatics, amines, ni-
tro-derivatives, and multifunctional compounds. In 
vivo and in vitro (predominantly, with liver micro-
somes as experimental systems) studies were used 
to analyze the metabolic fate of chemicals.  Differ-
ent sources, including monographs, scientific articles 
and public websites were used to compile the data-
base (10).
RESULTS AND DISCUSSION
The results of the probable metabolic activation 
in liver (observed and predicted) of some phenolic 
compounds are presented in Table 2. They are ran-
domly selected because they are a main component 
in many plants. 
The obtained results correspond with an im-
portant health care role of these compounds (20). Fe-
rulic, sinapic acids and chlorgenic acids (21) are anti-
oxidants and are reactive towards free radicals such 
as reactive oxygen species (ROS). Similar effects are 
also possessed by the mentioned flavonoids luteolin, 
myricetin and kaemferol (4,8,22). ROS and free rad-
icals are implicated in DNA damage, cancer and ac-
celerated cell aging. 
Electrophilic metabolites may not only react 
with nucleophilic sites in DNA but may also bind 
to proteins, RNA, and to endogenous substances of 
lower molecular weight such as glutathione (12). The 
complexity of the reaction of electrophilic metabo-
lites with the various nucleophilic sites within cells 
and the reasons why different electrophilic reagents 
react at different sites have been interpreted on the 
basis of the concepts of hard and soft electro philes/
nucleophiles (hard and soft acids/bases) (13,16,17).
Analysis of data in Table 2 reveals that after 
metabolic activation in liver (observed pathways) for 
five of the six plant phenolic compounds by (Q)SAR 
Application Toolbox liver metabolism was not ob-
served. Only for one compound (Luteolin) of the six 
metabolic activation in liver (observed pathways) was 
observed. The Luteolin has three observed metabo-
lites and 0 predicted metabolites in the liver. The ob-
served metabolites have no DNA binding but some of 
these metabolites have protein binding. The possible 
mechanism of protein binding for the observed me-
tabolites is Michael-type nucleophilic addition.
One (Myricetin) of the six phenolic compounds 
was not metabolically activated in liver. The Chloro-
genic acid was metabolically activated in liver (ob-
served and predicted metabolism) but its two predict-
ed metabolites were not active – no protein binding.
Kaemferol is a phenolic compound which has 
one predicted metabolite. The possible mechanism of 
protein binding for the predicted metabolite is Mi-
chael-type nucleophilic addition. The Sinapinic acid 
has thirteen predicted metabolites. Predicted metab-
olites have no DNA binding but some of these metab-
olites have protein binding. Possible mechanisms of 
protein binding for the observed metabolites are Mi-
chael-type nucleophilic addition, Schiff base forma-
tion and Nucleophilic cycloaddition to diketones. Fe-
rulic acid has eleven predicted metabolites. The pre-
dicted metabolites have no DNA binding but some 
3)
5 Kaemferol 0 metabolites: 1 metabolite: 
- Protein binding – Michael-type nucleophilic 
addition; 
             - DNA binding - No binding; 
1)
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of these metabolites have protein binding. Probable 
mechanisms of protein binding of the predicted me-
tabolite for Ferulic acid are Michael-type nucleophil-
ic addition, Schiff base formation and Nucleophilic 
cycloaddition to diketones.
CONCLUSION
Plant phenols play an important role in human 
health. There is numerous data on the beneficial 
effects during their application. All this requires an 
assessment of potential adverse effects on hepatic 
metabolism and the ability to induce liver injury.
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